SCHEMBL4180718

SCHEMBL4180718

NC(CC(=O)O)Oc1ccc(F)cc1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PPARG P37231 2/20 0.47
PPARA Q07869 2/20 0.47
FFAR1 O14842 2/20 0.47
ALDH1A1 P00352 4/20 0.46
LTA4H P09960 1/20 0.44
NPSR1 Q6W5P4 1/20 0.43
FNTA P49354 1/20 0.42
FNTB P49356 1/20 0.42
SMN1; SMN2 Q16637 2/20 0.40
HPGD P15428 1/20 0.39
LMNA P02545 1/20 0.39
GAA P10253 1/20 0.39
NR4A2 P43354 1/20 0.39
SLC6A9 P48067 2/20 0.39
CYP2D6 P10635 1/20 0.39
MAPT P10636 1/20 0.39
CYP2C9 P11712 1/20 0.39
CYP2C19 P33261 1/20 0.39
SLC6A5 Q9Y345 1/20 0.39
MAOB P27338 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4170593 0.83 KMT2A (0.45) PPARGPPARAFFAR1LTA4HSMN1; SMN2
SCHEMBL4187187 0.82 LDHA (0.55) PPARGPPARAFFAR1ALDH1A1NPSR1
SCHEMBL4183100 0.82 RXRA (0.39) FFAR1LTA4H
SCHEMBL4187784 0.82 L3MBTL1 (0.47) PPARGPPARAFFAR1ALDH1A1FNTA
SCHEMBL4173523 0.82 PPARG (0.50) PPARGPPARALTA4HLMNACYP2D6
SCHEMBL2108302 0.79 ALDH1A1 (0.50) PPARGPPARAFFAR1ALDH1A1NPSR1
SCHEMBL2108300 0.79 ALDH1A1 (0.50) PPARGPPARAFFAR1ALDH1A1NPSR1
SCHEMBL21991330 0.76 NPSR1 (0.48) PPARGPPARAFFAR1ALDH1A1NPSR1
Hydrochloric Acid SCHEMBL18939596 0.75 LTA4H (0.47) FFAR1LTA4HFNTAFNTBSMN1; SMN2
SCHEMBL4655106 0.75 NPSR1 (0.47) PPARGPPARAFFAR1ALDH1A1NPSR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090227680-A1 Amino Acid Derivatives PFIZER, INC. (US) 2009-09-10 US claimed
EP-1951655-A2 AMINO ACID DERIVATIVES Pfizer Limited (GB) 2008-08-06 EP claimed
WO-2007057767-A2 AMINO ACID DERIVATIVES PFIZER LIMITED (GB) 2007-05-24 WO claimed
US-20090227680-A1 Amino Acid Derivatives PFIZER, INC. (US) 2009-09-10 US disclosed
EP-1951655-A2 AMINO ACID DERIVATIVES Pfizer Limited (GB) 2008-08-06 EP disclosed
WO-2007057767-A2 AMINO ACID DERIVATIVES PFIZER LIMITED (GB) 2007-05-24 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090227680-A1 Amino Acid Derivatives OPRL1, OPRK1, AVPR1A PPARG 2322/4885PPARA 1589/4885FFAR1 497/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.